These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 26618209)
21. Agreement reached on virus testing and protections for doctors. Ir Med J; 2008 Apr; 101(4):126. PubMed ID: 18557519 [No Abstract] [Full Text] [Related]
22. Viral hepatitis. Gurevich I Am J Nurs; 1983 Apr; 83(4):571-86. PubMed ID: 6404169 [No Abstract] [Full Text] [Related]
23. Effectiveness of hepatitis B vaccination. Inaba S; Ito A; Miyata Y; Tadokoro K; Kikuchi S Infect Control Hosp Epidemiol; 2006 Jan; 27(1):101-2. PubMed ID: 16528867 [No Abstract] [Full Text] [Related]
24. [Preventive vaccination for viral hepatitis]. Jilg W Z Gastroenterol; 1997 Jul; 35(7):585-90. PubMed ID: 9340933 [TBL] [Abstract][Full Text] [Related]
26. Viral hepatitis A, B, and C: grown-up issues. Sharapov UM; Hu DJ Adolesc Med State Art Rev; 2010 Aug; 21(2):265-86, ix. PubMed ID: 21047029 [TBL] [Abstract][Full Text] [Related]
27. Universal precautions: attitudes of Australian and New Zealand anaesthetists. Richards MJ; Jenkin GA; Johnson PD Med J Aust; 1997 Feb; 166(3):138-40. PubMed ID: 9059436 [TBL] [Abstract][Full Text] [Related]
28. Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection. Ingiliz P; Krznaric I; Obermeier M AIDS; 2013 Feb; 27(4):667-8. PubMed ID: 23364445 [No Abstract] [Full Text] [Related]
29. ECDC report on the responses in the EU/EEA to hepatitis B and C. Kohl S Eur J Hosp Pharm; 2020 Jul; 27(4):244-247. PubMed ID: 32587086 [No Abstract] [Full Text] [Related]
32. Editorial commentary regarding prevention of blood borne diseases in the health care setting (Sep/Oct '99). Molloy C Ir Med J; 1999; 92(7):440. PubMed ID: 10967872 [No Abstract] [Full Text] [Related]
34. [Hepatitis A, B, C and D. Epidemiology, etiology, diagnosis, development, prevention]. Buffet C Rev Prat; 1995 May; 45(10):1299-304. PubMed ID: 7659978 [No Abstract] [Full Text] [Related]
35. [Immunoprophylaxis of viral hepatitis]. Biesiada G; Mach T Przegl Lek; 2003; 60(9):598-601. PubMed ID: 15065341 [TBL] [Abstract][Full Text] [Related]
36. [Epidemiological aspects of viral hepatitis: immunogenicity of hepatitis B vaccine administered to children and adolescents]. del Rey Calero J An R Acad Nac Med (Madr); 1992; 109(2):261-96; discussion 296-8. PubMed ID: 1463144 [No Abstract] [Full Text] [Related]
37. Accuracy of perceptions of hepatitis B and C status. Injecting drug users need vaccination against hepatitis B. Ramsay ME; Balogun MA; Teo CG; Mortimer PP BMJ; 2000 Feb; 320(7233):512; author reply 513. PubMed ID: 10678875 [No Abstract] [Full Text] [Related]
38. [Chronic hepatitis B and C. Epidemiology, diagnosis, course, prevention]. Buffet C Rev Prat; 1997 Apr; 47(7):791-7. PubMed ID: 9183956 [No Abstract] [Full Text] [Related]
39. [Vaccination against hepatitis A and B in HCV-infected patient?]. Blum E Internist (Berl); 1998 Sep; 39(9):980. PubMed ID: 9788121 [No Abstract] [Full Text] [Related]
40. [Seroprevalence of hepatitis B and C viruses in a psychiatric institution]. Eveillard M; Daroukh A; Desjardins P; Legrand S; Odzo-Gakala M; Bourlioux P Pathol Biol (Paris); 1999 May; 47(5):543-8. PubMed ID: 10418037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]